Similarly, patients with triple negative gliomas had poorer overall survival than gliomas with TERT, IDH, or triple positive gliomas.  Of note among Grade IV gliomas, the molecular subgroups assigned in this study were not associated with survival differences in multivariate analyses. The gene discussed is IDH1; the disease is central nervous system cancer.